Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest NeoGenomics Inc. Stories

2011-07-20 06:00:00

FT. MYERS, Fla., July 20, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the second quarter 2011. Second Quarter 2011 Highlights: 23% revenue growth 27% test volume growth Incremental profit of $685,000, or 35% of the year-over-year revenue increase Net loss reduced to $(0.01)/share from $(0.03)/share in Q2 2010 Positive Adjusted EBITDA(1) Revenue for the second quarter 2011 was...

2011-07-12 18:13:00

FT. MYERS, Fla., July 12, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ-OTCBB: NGNM) announced today that it plans to release its second quarter 2011 financial results on Wednesday, July 20, 2011. The Company has scheduled a web-cast and conference call to discuss their Q2 2011 results on July 20, 2011, at 11:00 AM Eastern Daylight Time. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior to the call. A replay of the...

2011-04-21 06:00:00

FT. MYERS, Fla., April 21, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2011. First Quarter 2011 Highlights: Revenue growth of 5% vs. Q1 10 despite impacts from severe winter weather Test volume growth of 10% vs. Q1 10 Increases in sales force productivity throughout quarter Revenue for the first quarter 2011 was $8.8 million, a 5% increase over first quarter...

2011-04-15 14:17:00

FORT MYERS, Fla., April 15, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its first quarter 2011 financial results on Thursday, April 21, 2011. The Company has scheduled a web-cast and conference call to discuss their Q1 2011 results on April 21, 2011, at 11:00 AM eastern time. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior to the call. A replay of the...

2011-02-10 06:00:00

FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010. Fourth Quarter 2010 Highlights: Revenue growth of 12% Adjusted EBITDA positive Average revenue per test stabilized Diluted loss per share of $(0.01) Revenue for the fourth quarter 2010 was approximately $8.8 million, a 12% increase...

2011-02-10 05:30:00

FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services announced today that Kevin C. Johnson and Raymond R. Hipp have joined its Board of Directors. Mr. Johnson's appointment was effective October 28, 2010 and filled the vacancy created by the resignation of Mr. George O'Leary. Mr. Hipp's appointment was effective as of February 3, 2011 and filled the vacancy created by the resignation of...

2011-02-04 14:49:00

FT. MYERS, Fla., Feb. 4, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it plans to release its fourth quarter and full year 2010 financial results on Thursday, February 10, 2011. The Company has scheduled a web-cast and conference call to discuss their Q4 and Full Year 2010 results on February 10, 2011, at 11:00 AM eastern time. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior...

2011-01-12 06:00:00

FT. MYERS, Fla., Jan. 12, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it has completed a $3.0 million equity financing transaction. Five members of the Company's Board of Directors and senior management team and two existing institutional investors of the Company participated in the transaction. The transaction was priced at $1.50 per share and resulted in 2.0 million shares of new common stock being issued by the Company. No warrants were...

2011-01-11 06:00:00

FT. MYERS, Fla., Jan. 11, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) announced today that it has been notified that the Qui Tam complaint filed against it and several other healthcare companies in 2009 has been voluntarily dismissed with prejudice by the relator in the case. As a result, no further action will be taken against NeoGenomics in this matter. Douglas VanOort, the Company's Chairman and CEO, stated, "We are pleased, but not surprised that this case...

2010-11-15 06:00:00

FT. MYERS, Fla., Nov. 15, 2010 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it will present at the Lazard Capital Markets 7th Annual Healthcare Conference being held November 16-17, 2010, at the St. Regis, New York Hotel in New York City. The conference will showcase public and private life sciences and biotech companies. Senior executives of attending companies will make presentations to portfolio managers and analysts on their business...